Skip to main content

Ivan T. Shaw, PhD

Written by TVM Capital Life Science on . Posted in Investment Team.

A neurobiologist by training, Ivan is an experienced pharmaceutical industry professional with broad expertise in the full lifecycle of pharmaceutical development, medical affairs and regulatory affairs, encompassing discovery stage pre-clinical development of candidate assets through to post-marketing lifecycle management in adult, pediatric and orphan indications for small molecules, biologics and gene therapy.

Ivan has served as the CEO for multiple project-focused companies developing oncology, immunology and neuroscience therapeutic assets to Proof of Concept. He has also held the position of Vice-President, Clinical Development with enGene Inc., Medical Director with Actavis LLC, and Director Clinical Development with Aptalis Pharma Inc.

Ivan received his Doctorate in Neurological Sciences/Neurology and Neurosurgery from McGill University, Montréal, Canada.